Skip to main content

Advertisement

Table 6 Clinical Outcome of non-diabetes subjects based on MAGE levels during in-hospital and 30-day follow-up

From: Effect of glycemic variability on short term prognosis in acute myocardial infarction subjects undergoing primary percutaneous coronary interventions

MAGE (mmol/L)   <2.21 2.21-3.38 >3.38 P
Subject number (n) 164 55 55 54 NA
Composite MACE 17 (10.4) 4 (7.3) 6 (10.9) 7 (13) 0.614
Non-IRA revascularization 26 (15.9) 7 (12.7) 9 (16.4) 10 (18.5) 0.704
  1. Data given as mean ± SD or n (%).
  2. MAGE, the mean amplitude of glycemic excursions; MACE, major adverse cardiac events; TVR, target vessel revascularization; IRA, infarct related arteries.